-
Annual Review | Dr. Yao Zhu: Advances in Surgical Diagnosis and Treatment of Prostate Cancer in 2024
As 2024 concludes, the field of minimally invasive urological surgery has made remarkable strides, particularly in prostate cancer surgery, which often serves as a testing ground for innovative surgical approaches. With the advancement of precision medicine and multidisciplinary team (MDT) management, prostate cancer surgery now extends beyond simple tumor removal, incorporating preoperative diagnostic optimization, postoperative…
-
SABCS 2024: Advancing Metastatic Breast Cancer Care with Digital PRO Monitoring
At the San Antonio Breast Cancer Symposium (SABCS 2024), Dr. Maria Margarete Karsten and her team presented groundbreaking findings from the PRO B trial, a multicenter study evaluating the impact of alert-based patient-reported outcome (PRO) monitoring in metastatic breast cancer patients.
-
Breakthrough in Gastric Cancer Treatment: Updated Efficacy of ASKB589 Combo Therapy
Study Rationale G/GEJ adenocarcinomas are among the most aggressive malignancies, necessitating the exploration of novel therapeutic strategies to improve patient outcomes. A promising investigational agent, ASKB589, is currently being evaluated…
-
Frontline FOLFOXIRI, Bevacizumab, and Cadonilimab: A Promising Combo for pMMR Metastatic Colorectal Cancer
Methods The SYLT-026 trial is a multicenter, single-arm phase II study enrolling treatment-naïve patients diagnosed with pMMR/MSS mCRC. Eligible patients were between 18 and 75 years old, had at least…
-
Annual Review | Dr. Xu Zhou: Key Advances in the Treatment of Cholangiocarcinoma
1. Classification and Current Status of BTC Since 2010, experts have classified intrahepatic cholangiocarcinoma (ICC) as part of BTC and established an independent staging system. According to the 2022 CSCO…
-
Dr. Anqin Zhang: Current Status, Challenges, and Future Directions for Breast Cancer Screening in Young Women | 2024 Yixian Breast Cancer Conference
The increasing prevalence of breast cancer among younger women poses significant challenges for early detection and treatment. At the 2024 Yixian Breast Cancer Conference and the 2nd China Young Breast Cancer Consensus Conference, Dr. Anqin Zhang from Guangdong Women and Children’s Hospital provided an in-depth analysis of the current status and issues surrounding breast cancer…
-
Dr. Yaping Yang: Characteristics and Personalized Treatment Strategies for Young Breast Cancer Patients | 2024 Yixian Breast Cancer Conference
Editorial Note: The 2024 Yixian Breast Cancer Conference and the 2nd China Young Breast Cancer Consensus Conference, held on December 27–28 in Guangzhou, focused on cutting-edge topics such as the changing epidemiology of young breast cancer, screening strategies, the impact of genetic mutations, treatment, and rehabilitation. During the conference, Dr. Yaping Yang from Sun Yat-sen…
Connecting Medical Expertise through Media
